-
Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline
Forbes | What drugs is Moderna developing? It finally gives some details at JP Morgan.
Jan 9, 2017
-
PatientsLikeMe Joins Wang's iCarbonX Digital Life Alliance Cornerstone
Diagnostics World | Last week PatientsLikeMe announced a partnership and investment from iCarbonX that positions PatientsLikeMe as the cornerstone of Jun Wang's iCarbonX Digital Life Alliance, which aims to digitize and analyze all aspects of life.
Jan 9, 2017
-
Will Our Government’s Multi-Billion-Dollar Investment In Genome Science Pay Off?
Pacific Standard | Though the medical benefits of genome science have been marginal thus far, the government's multi-billion-dollar investment could pay off with the right policy adjustments.
Jan 9, 2017
-
Interference: A CRISPR Patent Dispute Roadmap
Bio-IT World | An epic CRISPR litigation battle between a host of universities has erupted involving CRISPR/Cas9, which can have major implications for the gene-editing technology community.
Jan 9, 2017
-
Guide RNA Synthesis Firm Synthego Gets Investment, Vote Of Doudna Confidence
Bio-IT World This week Synthego, a leading provider of genome engineering solutions, announced a $41 million Series B financing, bringing the company’s total fundraising to $50 million. The latest round includes investment from several venture firms, as well as direct, individual investments from Jennifer Doudna and Jamie Cate.
Jan 6, 2017
-
BioTeam’s Berman Charts 2017 HPC Trends in Life Sciences
HPCwire | Twenty years ago high performance computing was nearly absent from life sciences. Today it's used throughout life sciences and biomedical research. Genomics and the data deluge from modern lab instruments are the main drivers, but so is the longer-term desire to perform predictive simulation in support of Precision Medicine (PM).
Jan 6, 2017
-
Boston Biotech Pieris Nabs Cancer Deal With French Powerhouse Servier
Bio-IT World News Brief | Pieris and Servier today announced a broad collaboration in immuno-oncology. Under the collaboration, Pieris and Servier will initially pursue five bispecific therapeutic programs.
Jan 5, 2017
-
WuXi NextCODE Chosen To Support Singapore Precision Medicine Pilot
Bio-IT World | The National Heart Centre of Singapore (NHCS) has chosen WuXi NextCODE to support its 18-month proof-of-concept precision medicine project, focusing on cardiovascular disease.
Jan 4, 2017
-
Edico Genome’s Deal with Dell EMC Fits Partnership Strategy
Xconomy | San Diego's Edico Genome is now in its fourth year as a startup, and well into the hard slog of striking partnership deals, generating revenue, and building a business.
Jan 4, 2017
-
AstraZeneca CIO Makes IT Twice As Good At Half The Cost - Here Is How
Forbes | Dave Smoley has led a remarkable transformation of the information technology function at AstraZeneca during his nearly four years as CIO. He has codified the methods used to double IT's value at half the cost in ways that others can follow, as well.
Jan 3, 2017
-
Gene Therapy To Prevent Inherited Diseases May Cause Other Ills
NPR.org | In 2016, scientists combined the genes of three people in an effort to make a baby free of an inherited disease. But the process doesn't wipe out all faulty mitochondria, and could pose new risks.
Jan 3, 2017
-
University of California Sues For Genia Technology Rights
Bio-IT World Brief | Yesterday the Regents of the University of California filed a patent suit against Roger Chen and Genia Technologies in California Northern District Court.
Dec 30, 2016
-
Building For The Future Aurora Supercomputer At Argonne
insideHPC | Argonne National Laboratory is working on its next generation computing system: Aurora.
Dec 29, 2016
-
How Blockchain Can Create the World’s Biggest Supercomputer
TechCrunch | As our desktop computers, laptops, mobile devices, etc. stand idly by for a huge portion of the day, the need for computing resources is growing at a fast pace.
Dec 28, 2016
-
Five Big Idea Biotech Trends to Watch in 2017
Forbes | There's something especially fun about talking with scientific entrepreneurs who raised their first big wad of investment cash. They're latching onto some kernel of insight from a discovery. Here were a few trends I observed from covering startups which raised issues that will remain relevant in the year ahead.
Dec 28, 2016
-
Local Stem Cell Biotech Mesoblast Wins Key US Investor Backing
WA Today | The embattled stem cell biotech has seen a major US drug company becoming a cornerstone investor and taking an option over two of its main products.
Dec 23, 2016
-
Genohub Adds Storage, Project Management Guarantees to Sequencing Marketplace
Bio-IT World | Three years after its launch, Genohub is refining its mission, focusing on process and user experience more than just transactions.
Dec 21, 2016
-
Editas Medicine, Mass Innovation Labs, Sinequa, And More: News From December 2016
Bio-IT World News Brief | News, products, and partnerships from around the bio-IT community including news from Editas Medicine, Mass Innovation Labs, Sinequa, and more.
Dec 19, 2016
-
Scientists Say the Clock of Aging May Be Reversible
The New York Times | The technique, discovered by a team at the Salk Institute and tested in mice, cannot be applied directly to people, but it points toward better understanding of human aging.
Dec 19, 2016
-
Modernas Mysterious Medicines
Forbes | Backed by world-class science, a stealthy biotech has raised $1.9 billion by promising to change medicine forever. A new lawsuit opens a rare window into its secrets.
Dec 15, 2016